SSHA

Society of Sexual Health Advisers

Unite the union
  • About us
    • JOIN SSHA
    • Code of Professional Conduct
    • National Organising Professional Committee
    • National Organising Professional Committee Structure
    • Constitution and Rules
    • Council Reports
    • NPC ACCESS ONLY
  • News
  • Regions
    • London
    • North East, Yorkshire & Humberside
    • Ireland
    • Scotland
    • South West
    • East Midlands – VACANT
    • North West
    • South East
    • Wales
    • West Midlands
  • Resources
    • I Want To Be A Health Adviser
    • SSHA Manual
    • Conference Presentations
    • Competency Framework for Sexual Health Advisers
    • WeSSI: West Sussex Sexual Health Structured Interview
    • Research
    • Unite – Union
    • Publications
  • Jobs
    • Current Jobs
    • Sample Job Descriptions
  • Links
Home » 10,000 people will be given the “Prep” drug in a three-year-long clinical trial.

10,000 people will be given the “Prep” drug in a three-year-long clinical trial.

December 4, 2016 By SSHA Leave a Comment

HIV ‘game-changer’ now on NHS

A drug that dramatically reduces the risk of being infected with HIV will now be given to patients by the NHS in England.

The health service lost a court battle in the summer after arguing responsibility for paying for it should fall to local authorities not the NHS.

Now at least 10,000 people will be given the “Prep” drug in a three-year-long clinical trial.

NHS England says this will help them understand how to offer it more widely.

Pre-exposure prophylaxis or Prep is a daily pill that disables HIV before it gets a stranglehold in the body.

It costs £400 a month per person and trials suggest it can cut the risk of being infected by up to 86%.

NHS England, which fought not to offer the drug, said in a statement there was “strong” evidence that it was effective.

However, it said there were still questions to be answered about how it is used on a wide scale across England.

Large-scale trial

Its trial on at least 10,000 people will try to figure out how to get the drugs to the right people, how popular it would be and for how long they would take Prep.

Dr Ian Williams, chairman of NHS England’s group on HIV, said: “This announcement demonstrates NHS England’s commitment to fund Prep and provides the chance to best prepare England for optimal roll-out following this large-scale clinical trial.

“For now, the trial will provide access to Prep for thousands of people most at risk of acquiring HIV.”

Men who have sex with men are one of the groups at the highest risk of contracting HIV.

In London, one in eight gay men has HIV, while the proportion in the rest of the UK is one in 26.

Harry Dodd, 25, is one of about 500 homosexual men in England who are taking Prep as part of a trial called Proud.

He says: “I’ve seen the panic on the face of previous boyfriends when they are awaiting their [HIV test] results – it’s a huge fear and it affects everything you do.
“To be able to have sex without having that fear hanging over you all the time is huge.”

Harry says taking Prep has still not become socially acceptable.

“Too many people seem to think it will encourage a hedonistic lifestyle, but for me this is about saving lives,” he says.

“People reacted with cynicism when the contraceptive pill for women was first introduced.

“For me, taking Prep has helped me to trust again, have relationships and build bridges and that shouldn’t be taken away.”

Dr Michael Brady, medical director of the Terrence Higgins Trust, said the evidence on Prep was “overwhelming” but the new trial could help understand how it will work in real life.

He added: “However, we do still need answers to many questions about the trial, in terms of how exactly the trial will work in practice, how those at risk will be able to access Prep, no matter where they live, and what will happen after the trial.”

Deborah Gold, chief executive of the National Aids Trust, said: “We are absolutely delighted that following our wins in court, NHS England, working with Public Health England and local government, will be now making Prep available on a large scale, and quickly, to those who need it.”

The NHS in Wales, Scotland and Northern Ireland have not yet made a decision on Prep.

By James Gallagher
Health and science reporter, BBC News website
Original Article

Filed Under: Latest SSHA News, Media Watch Tagged With: Deborah Gold, Harry Dodd, hiv, Ian Williams, michael brady, NHS, nhs england, prep

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

About SSHA

The Society of Sexual Health Advisers (SSHA) is a UK national organisation with approximately 300 members out of an estimated 350 sexual health advisers in the country. It provides an opportunity for members to meet and work towards further professional development.

Recent Posts

  • Helping People to Reduce Sexual Health Risk: A Motivational Interviewing Approach February 28, 2023

Useful Links

  • BASHH
  • HPV Action
  • NAM
  • Public Health England
  • Public Health Scotland
  • Terence Higgins Trust
  • UNITE the Union

Copyright © 2023 · SSHA - Society of Sexual Health Advisers

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT